Growth Metrics

Idexx Laboratories (IDXX) Total Current Liabilities (2016 - 2025)

Idexx Laboratories has reported Total Current Liabilities over the past 17 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly results put Total Current Liabilities at $1.1 billion for Q4 2025, up 7.58% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (up 7.58% YoY), and the annual figure for FY2025 was $1.1 billion, up 7.58%.
  • Total Current Liabilities for Q4 2025 was $1.1 billion at Idexx Laboratories, down from $1.3 billion in the prior quarter.
  • Over the last five years, Total Current Liabilities for IDXX hit a ceiling of $1.3 billion in Q3 2025 and a floor of $620.7 million in Q1 2021.
  • Median Total Current Liabilities over the past 5 years was $1.0 billion (2023), compared with a mean of $1.0 billion.
  • Biggest five-year swings in Total Current Liabilities: fell 26.66% in 2021 and later skyrocketed 87.73% in 2022.
  • Idexx Laboratories' Total Current Liabilities stood at $763.6 million in 2021, then surged by 61.84% to $1.2 billion in 2022, then dropped by 23.0% to $951.5 million in 2023, then grew by 12.23% to $1.1 billion in 2024, then rose by 7.58% to $1.1 billion in 2025.
  • The last three reported values for Total Current Liabilities were $1.1 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.2 billion (Q2 2025) per Business Quant data.